{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:05:57Z","timestamp":1790143557613,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health, USA","doi-asserted-by":"crossref","award":["MH-26341"],"award-info":[{"award-number":["MH-26341"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health, USA","doi-asserted-by":"crossref","award":["MH-068688"],"award-info":[{"award-number":["MH-068688"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.psychres.2017.06.069","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T19:17:20Z","timestamp":1498159040000},"page":"267-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia"],"prefix":"10.1016","volume":"256","author":[{"given":"Martin","family":"Harrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Jobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Faull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2017.06.069_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1524-4733.2008.00495.x","article-title":"Health related quality of life (HRQL) and continuous antipsychotic treatment: 3 year results from the schizophrenia health outcomes (SOHO) study","volume":"12","author":"Alonso","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.psychres.2017.06.069_bib2","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ps.201500408","article-title":"Is the evidence strong enough to warrant long-term antipsychotic use in compulsory outpatient treatment?","author":"Barnes","year":"2016","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2017.06.069_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00213-006-0578-x","article-title":"The debate over dopamine's role in reward: the case for incentive salience","volume":"191","author":"Berridge","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2017.06.069_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archpsyc.1978.01770250074007","article-title":"Prognosis in schizophrenia: prognostic predictors and outcome","volume":"35","author":"Bland","year":"1978","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib5","series-title":"The Schizophrenic Disorders: Long-Term Patient and Family Studies","author":"Bleuler","year":"1978"},{"key":"10.1016\/j.psychres.2017.06.069_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/17522430802610008","article-title":"Psychosocial treatment, antipsychotic postponement, and low dose medication strategies in first episode psychosis: a review of the literature","volume":"1","author":"Bola","year":"2009","journal-title":"Psychosis"},{"key":"10.1016\/j.psychres.2017.06.069_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.wpsyc.2012.01.005","article-title":"Generalizability of the individual placement and support (ips) model of supported employment outside the US","volume":"11","author":"Bond","year":"2012","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 Schizophrenia PORT psychopharmacological treatment recommendations and summary statements","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2017.06.069_bib9","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1001\/archpsyc.1992.01820120054008","article-title":"Striatal metabolic rate and clinical response to neuroleptics in schizophrenia","volume":"49","author":"Buchsbaum","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1192\/bjp.128.4.397","article-title":"Evaluating signs and symptoms: comparison of structured interview and clinical approaches","volume":"128","author":"Carpenter","year":"1976","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1176\/ajp.137.1.16","article-title":"Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics","volume":"137","author":"Chouinard","year":"1980","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib12","first-page":"140","article-title":"Soteria Berne: an innovative milieu therapeutic approach to acute schizophrenia based on the concept of affect-logic","volume":"3","author":"Ciompi","year":"2004","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archpsyc.1978.01770310043002","article-title":"A diagnostic interview","volume":"35","author":"Endicott","year":"1978","journal-title":"Arch. Gen. Psychiat."},{"key":"10.1016\/j.psychres.2017.06.069_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2045125311431105","article-title":"Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients","volume":"2","author":"Fallon","year":"2012","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.psychres.2017.06.069_bib15","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1176\/ajp.144.10.1306","article-title":"Sustained remission in drug-free schizophrenic patients","volume":"144","author":"Fenton","year":"1987","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archpsyc.1995.03950150041008","article-title":"Considering neuroleptic maintenance and taper on a continuum: need for individual rather than dogmatic approach","volume":"52","author":"Gilbert","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1176\/ajp.153.3.321","article-title":"What are the functional consequences of neurocognitive deficits in schizophrenia?","volume":"153","author":"Green","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.schbul.a033430","article-title":"Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the \"right stuff\"?","volume":"26","author":"Green","year":"2000","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2017.06.069_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/aje\/kwf215","article-title":"Statistical analysis of correlated data using generalized estimating equations: an orientation","volume":"157","author":"Hanley","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.psychres.2017.06.069_bib20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1176\/ajp.144.6.727","article-title":"The Vermont longitudinal study of persons with severe mental illness: II. long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia","volume":"144","author":"Harding","year":"1987","journal-title":"Am. J. Psychiat"},{"key":"10.1016\/j.psychres.2017.06.069_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00005053-198706000-00001","article-title":"Work and mental illness: I. Toward an integration of the rehabilitation process","volume":"175","author":"Harding","year":"1987","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.psychres.2017.06.069_bib22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.nmd.0000253783.32338.6e","article-title":"Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: A 15-year multi-followup study","volume":"195","author":"Harrow","year":"2007","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.psychres.2017.06.069_bib23","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/schbul\/sbt034","article-title":"Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery?","volume":"39","author":"Harrow","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2017.06.069_bib24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archpsyc.1990.01810190065009","article-title":"Outcome in manic disorders: a naturalistic followup study","volume":"47","author":"Harrow","year":"1990","journal-title":"Arch. Gen. Psychiat."},{"key":"10.1016\/j.psychres.2017.06.069_bib25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/schbul\/sbi026","article-title":"Do patients with schizophrenia ever show periods of recovery?: A 15 year multi-followup study","volume":"31","author":"Harrow","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2017.06.069_bib26","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1017\/S0033291712000220","article-title":"Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study","volume":"42","author":"Harrow","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2017.06.069_bib27","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1017\/S0033291714000610","article-title":"Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study","volume":"44","author":"Harrow","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2017.06.069_bib28","series-title":"The Creation of Psychopharmacology","author":"Healy","year":"2002"},{"key":"10.1016\/j.psychres.2017.06.069_bib29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.schbul.a007134","article-title":"Are negative symptoms associated with functioning deficits in both schizophrenic and non-schizophrenic patients? A ten-year longitudinal analysis","volume":"30","author":"Herbener","year":"2004","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2017.06.069_bib30","series-title":"Social Class and Mental Illness","author":"Hollingshead","year":"1958"},{"key":"10.1016\/j.psychres.2017.06.069_bib31","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment: meta-analysis of imaging studies","volume":"69","author":"Howes","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib32","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.psychres.2017.06.069_bib33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/schbul\/sbm151","article-title":"What did the WHO studies really find?","volume":"34","author":"Jablensky","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2017.06.069_bib34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/0963721410378034","article-title":"Schizophrenia course, long-term outcome, recovery, and prognosis","volume":"19","author":"Jobe","year":"2010","journal-title":"Curr. Dir. Psychol. Sci."},{"key":"10.1016\/j.psychres.2017.06.069_bib35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1192\/bjp.157.2.182","article-title":"Further investigation of the predictors of outcome following first schizophrenic episodes","volume":"157","author":"Johnstone","year":"1990","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib36","doi-asserted-by":"crossref","DOI":"10.1017\/S0033291716000775","article-title":"Symptoms, functioning and coping strategies in individuals with schizophrenia spectrum disorders who do not take antipsychotic medication: a comparative interview study","author":"Jung","year":"2016","journal-title":"Psychol. Med. Adv. Access"},{"key":"10.1016\/j.psychres.2017.06.069_bib37","first-page":"5","article-title":"Maintenance treatment with antipsychotic drugs for schizophrenia","author":"Leucht","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psychres.2017.06.069_bib38","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","author":"Leucht","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2017.06.069_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using Generalized Linear Models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.psychres.2017.06.069_bib40","series-title":"Generalized Linear Models","author":"McCullagh","year":"1989"},{"key":"10.1016\/j.psychres.2017.06.069_bib41","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/jamapsychiatry.2013.264","article-title":"Antipsychotic medication during the critical period following remission from first-episode psychosis: less is more","volume":"70","author":"McGorry","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1037\/prj0000020","article-title":"Mental health system funding of cognitive enhancement interventions for schizophrenia: summary and update of the New York Office of Mental Health expert panel and stakeholder meeting","volume":"36","author":"McGurk","year":"2013","journal-title":"Psychiatr. Rehabil. J."},{"key":"10.1016\/j.psychres.2017.06.069_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eurpsy.2011.06.009","article-title":"Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication\u2013A 10-year follow-up of the Northern Finland 1966 Birth Cohort study","volume":"28","author":"Moilanen","year":"2013","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib44","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/10673220902979896","article-title":"A critique of the dopamine hypothesis of schizophrenia and psychosis","volume":"17","author":"Moncrieff","year":"2009","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib45","series-title":"The Myth of the Chemical Cure: A Critique of Psychiatric Drug Treatment","author":"Moncrieff","year":"2009"},{"key":"10.1016\/j.psychres.2017.06.069_bib46","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-clinpsy-050212-185620","article-title":"Psychosocial treatments for schizophrenia","volume":"9","author":"Mueser","year":"2013","journal-title":"Annu Rev. Clin. Psychol."},{"key":"10.1016\/j.psychres.2017.06.069_bib47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1192\/bjp.bp.116.182683","article-title":"Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?","volume":"209","author":"Murray","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib48","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/archgenpsychiatry.2012.647","article-title":"National trends in the office-based treatment of children, adolescents, and adults with antipsychotics","volume":"69","author":"Olfson","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib49","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1176\/appi.ajp.163.3.411","article-title":"Barriers to employment for people with schizophrenia","volume":"163","author":"Rosenheck","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pnpbp.2013.10.003","article-title":"Is schizophrenia a dopamine supersensitivity psychotic reaction?","volume":"48","author":"Seeman","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/syn.20303","article-title":"Psychosis pathways converge via D2high dopamine receptors","volume":"60","author":"Seeman","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.psychres.2017.06.069_bib52","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/17522439.2011.595819","article-title":"The comprehensive open-dialogue approach in western lapland: II. Long-term stability of acute psychosis outcomes in advanced community care","volume":"3","author":"Seikkula","year":"2011","journal-title":"Psychosis"},{"key":"10.1016\/j.psychres.2017.06.069_bib53","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s002130000532","article-title":"Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study","volume":"152","author":"Silvestri","year":"2000","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.psychres.2017.06.069_bib54","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4140\/TCP.n.2014.797","article-title":"Improving the management of disruptive behavior and reducing antipsychotic medications in nursing facility residents","volume":"29","author":"Stefanacci","year":"2014","journal-title":"Consult. Pharmacist\u00ae"},{"key":"10.1016\/j.psychres.2017.06.069_bib55","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00005053-199712000-00001","article-title":"Long-term follow-up of patients hospitalized for schizophrenia, 1913 to 1940","volume":"185","author":"Stephens","year":"1997","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.psychres.2017.06.069_bib56","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archpsyc.1972.01750300011002","article-title":"The prediction of outcome in schizophrenia: I characteristics of outcome","volume":"27","author":"Strauss","year":"1972","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib57","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.psychres.2015.02.021","article-title":"Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia","volume":"227","author":"Suzuki","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2017.06.069_bib58","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2007.11.033","article-title":"World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia","volume":"100","author":"Tandon","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.06.069_bib59","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00005053-196212000-00006","article-title":"The prediction of recovery in schizophrenia","volume":"135","author":"Vaillant","year":"1962","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.psychres.2017.06.069_bib60","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/archpsyc.1964.01720290051007","article-title":"Prospective prediction of schizophrenic remission","volume":"11","author":"Vaillant","year":"1964","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib61","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/schbul\/4.1.78","article-title":"A 10-year followup of remitting schizophrenics","volume":"4","author":"Vaillant","year":"1978","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2017.06.069_bib62","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/schbul\/10.4.624","article-title":"Prognosis and outcome using broad DSM-II and narrow DSM-III concepts of schizophrenia","volume":"10","author":"Westermeyer","year":"1984","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2017.06.069_bib63","series-title":"Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill","author":"Whitaker","year":"2010"},{"key":"10.1016\/j.psychres.2017.06.069_bib64","series-title":"Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America","author":"Whitaker","year":"2011"},{"key":"10.1016\/j.psychres.2017.06.069_bib65","article-title":"Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis","author":"Wils","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.06.069_bib66","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamapsychiatry.2013.19","article-title":"Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction\/discontinuation or maintenance treatment strategy long-term follow-up of a 2-year randomized clinical trial recovery in remitted first-episode psychosis","volume":"70","author":"Wunderink","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2017.06.069_bib67","first-page":"2","article-title":"The developmental approach to adult psychopathology","volume":"54","author":"Zigler","year":"2001","journal-title":"Clin. Psychol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116321278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116321278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T18:15:41Z","timestamp":1602353741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178116321278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":67,"alternative-id":["S0165178116321278"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2017.06.069","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2017.06.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}